Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Amarin Corp ADR (AMRN)

Amarin Corp ADR (AMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 365,827
  • Shares Outstanding, K 410,672
  • Annual Sales, $ 306,910 K
  • Annual Income, $ -59,110 K
  • 60-Month Beta 2.01
  • Price/Sales 1.19
  • Price/Cash Flow N/A
  • Price/Book 0.62
Trade AMRN with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.14
  • Most Recent Earnings $0.00 on 02/29/24
  • Latest Earnings Date 05/01/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 104.23% ( +15.01%)
  • Historical Volatility 86.47%
  • IV Percentile 58%
  • IV Rank 31.19%
  • IV High 277.98% on 10/31/23
  • IV Low 25.49% on 11/16/23
  • Put/Call Vol Ratio 0.74
  • Today's Volume 590
  • Volume Avg (30-Day) 1,019
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 39,280
  • Open Int (30-Day) 40,282

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.05
  • Number of Estimates 2
  • High Estimate -0.04
  • Low Estimate -0.05
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8015 +11.14%
on 03/14/24
1.2500 -28.74%
on 02/29/24
-0.4292 (-32.52%)
since 02/28/24
3-Month
0.8015 +11.14%
on 03/14/24
1.3700 -34.98%
on 01/30/24
-0.0089 (-0.99%)
since 12/28/23
52-Week
0.6510 +36.84%
on 11/01/23
1.5580 -42.82%
on 03/29/23
-0.6392 (-41.78%)
since 03/28/23

Most Recent Stories

More News
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript

AMRN earnings call for the period ending December 31, 2023.

AMRN : 0.8908 (+0.18%)
Why Amarin Stock Skyrocketed Today

The biopharma company announced a big repurchase plan, along with strong preliminary Q4 results.

AMRN : 0.8908 (+0.18%)
Amarin Plc (AMRN) Q3 2023 Earnings Call Transcript

AMRN earnings call for the period ending September 30, 2023.

AMRN : 0.8908 (+0.18%)
Why Amarin Stock Is Sinking Today

The drugmaker announced a major corporate reorganization and a new CEO.

AMRN : 0.8908 (+0.18%)
Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript

AMRN earnings call for the period ending March 31, 2023.

AMRN : 0.8908 (+0.18%)
Amarin's (AMRN) Q1 Earnings Top, Vascepa Sales Fall

Amarin's (AMRN) first-quarter 2023 earnings and revenues beat estimates. Vascepa sales decline.

AMRN : 0.8908 (+0.18%)
RCUS : 18.88 (+3.68%)
ALLO : 4.47 (+0.22%)
OCUP : 2.01 (-0.50%)
Biotech/Drug Stocks' Q1 Earnings Due May 3: UTHR, PCRX & More

Let us take a look at what's in store for biotech/drug stocks UTHR, PCRX, CORT, AMRN and IONS, which are scheduled to report on May 3.

UTHR : 229.72 (-5.57%)
PCRX : 29.22 (+0.62%)
AMRN : 0.8908 (+0.18%)
CORT : 25.19 (-0.51%)
IONS : 43.35 (-2.93%)
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?

On CRISPR's (CRSP) first-quarter earnings call, investors will likely focus on its pipeline, especially its lead candidate exa-cel, due to the absence of marketed drugs.

VRTX : 418.01 (+0.17%)
AMRN : 0.8908 (+0.18%)
CRSP : 68.16 (-2.85%)
ALLO : 4.47 (+0.22%)
Perrigo (PRGO) to Report Q1 Earnings: What's in the Cards?

Perrigo's (PRGO) new products and products added through acquisitions are expected to have aided the company's top line in the soon-to-be-reported quarter.

PRGO : 32.19 (+2.32%)
AMRN : 0.8908 (+0.18%)
ARGX : 393.72 (-1.22%)
ALLO : 4.47 (+0.22%)
Zoetis (ZTS) to Report Q1 Earnings: What's in the Cards?

Higher sales of Zoetis' (ZTS) key drugs like Apoquel, Cytopoint, Simparica Trio, Librela and Solensia are likely to have driven first-quarter sales.

AMRN : 0.8908 (+0.18%)
ZTS : 169.21 (+0.42%)
RETA : 172.36 (+0.02%)
ALLO : 4.47 (+0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amarin Corporation plc is a commercial-stage pharmaceutical company focused on developing therapies, especially based on omega-3 fatty acid for treating cardiovascular diseases. The company's sole marketed drug, Vascepa (icosapent ethyl) is approved in the United States as an adjunct to diet for treating...

See More

Key Turning Points

3rd Resistance Point 0.9372
2nd Resistance Point 0.9236
1st Resistance Point 0.9072
Last Price 0.8908
1st Support Level 0.8772
2nd Support Level 0.8636
3rd Support Level 0.8472

See More

52-Week High 1.5580
Fibonacci 61.8% 1.2115
Fibonacci 50% 1.1045
Fibonacci 38.2% 0.9975
Last Price 0.8908
52-Week Low 0.6510

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar